CIK 0001782223 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pyxis Oncology, Inc.
Sign in to watch- Ticker
- PYXS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831160910
- Phone
- (617) 221-9059
- Business address
- 321 HARRISON AVENUE, BOSTON, MA, 02118
- Open-market buys, last 90 days
- $0
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-24 | Yanchik Connealy Pamela CFO and COO | Grant or award | +209,803 | 594,313 | ||
| 2023-03-24 | Yanchik Connealy Pamela CFO and COO | Returned to the company · Stock Option (Right to buy) | −322,265 | 0 | ||
| 2023-03-24 | Yanchik Connealy Pamela CFO and COO | Returned to the company · Stock Option (Right to buy) | −10,304 | 0 | ||
| 2023-03-24 | Yanchik Connealy Pamela CFO and COO | Grant or award · Stock Option (Right to buy) | +322,265 | 322,265 | ||
| 2023-03-24 | Yanchik Connealy Pamela CFO and COO | Grant or award · Stock Option (Right to buy) | +10,304 | 10,304 | ||
| 2023-03-24 | Feingold Jay Chief Medical Officer | Grant or award | +209,803 | 730,345 | ||
| 2023-03-24 | Feingold Jay Chief Medical Officer | Returned to the company · Stock Option (Right to buy) | −157,257 | 0 | ||
| 2023-03-24 | Feingold Jay Chief Medical Officer | Returned to the company · Stock Option (Right to buy) | −17,517 | 0 | ||
| 2023-03-24 | Feingold Jay Chief Medical Officer | Grant or award · Stock Option (Right to buy) | +157,257 | 157,257 | ||
| 2023-03-24 | Feingold Jay Chief Medical Officer | Grant or award · Stock Option (Right to buy) | +17,517 | 17,517 | ||
| 2023-03-24 | Wadhane Jitendra Chief Accounting Officer | Grant or award | +29,393 | 118,041 | ||
| 2023-03-24 | Wadhane Jitendra Chief Accounting Officer | Grant or award | +45,000 | 88,648 | ||
| 2023-03-24 | Wadhane Jitendra Chief Accounting Officer | Returned to the company · Stock Option (Right to buy) | −157,257 | 0 | ||
| 2023-03-24 | Wadhane Jitendra Chief Accounting Officer | Grant or award · Stock Option (Right to buy) | +157,257 | 157,257 | ||
| 2023-03-24 | Lewis-Hall Freda C Director | Grant or award | +139,355 | 206,186 | ||
| 2023-03-24 | HUMPHREY RACHEL Director | Grant or award | +58,064 | 58,064 | ||
| 2023-03-24 | FLAVIN JOHN L Director | Grant or award | +139,355 | 377,796 | ||
| 2023-03-24 | Cline Darren S Director | Grant or award | +139,355 | 216,186 | ||
| 2023-03-24 | Civik Thomas Director | Grant or award | +139,355 | 206,186 | ||
| 2023-03-17 | PFIZER INC 10% owner | Purchase | +1,811,594 | $2.76 | $5.0M | 5,952,263 |
Page 5 of 7 · 137 trades